News from NYU Langone Health
How Big Data And An A-List Board Turned Struggling NYU Langone Into A $14 Billion Hospital Powerhouse. (Fortune)
(8/14) NYU Langone Health’s transformation, driven by data and accountability, is credited to Robert I. Grossman, MD, dean and CEO, and Ken Langone, board chairman, who have led the institution from financial struggle to becoming one of the most efficient providers of high-quality care in the U.S., with innovations such as tuition-free medical education and an integrated dashboard tracking 800 metrics; Dr. Grossman’s successor, Alec Kimmelman, MD, PhD, the Anita Steckler and Joseph Steckler Chair, and professor, Department of Radiation Oncology, Perlmutter Cancer Center, and other leaders continue to expand the model into underserved areas, demonstrating its broader applicability beyond Manhattan, despite challenges like federal funding cuts.
How NYU Langone Earned US News’ Top Heart Care Ranking. (Becker's ASC Review)
(8/14) NYU Langone Health leaders attribute their top cardiology, heart and vascular surgery ranking in U.S. News & World Report’s 2025-26 Best Hospitals list to decades of investment, recruitment, and a culture focused on quality and patient outcomes, with Larry A. Chinitz, MD, the Alvin Benjamin and Kenneth Coyle, Sr. Family Professor of Medicine and Cardiac Electrophysiology, Department of Medicine, the Leon H. Charney Division of Cardiology, saying, “It required an enormous effort that included contributions from our patients and philanthropic involvement from our senior leadership,” while Glenn I. Fishman, MD, the William Goldring Professor of Medicine, Department of Medicine, professor, Departments of Biochemistry and Neuroscience, and vice chair, Research Department of Medicine, described the ranking as “a validation of decades of innovation and teamwork and a focus on patient outcomes.”
CMS Star Ratings Of US News’ 50 Top Heart Hospitals. (8/14) NYU Langone Health, which ranked first among U.S. News & World Report’s top 50 heart hospitals, received a five-star quality rating from CMS in 2025, with the star ratings reflecting performance across mortality, safety, readmission, patient experience, and timely and effective care metrics.
American Hospital Association Elects New Members To Board Of Trustees. (Newsweek)
(8/14) Debra Albert, DNP, MBA, RN, NEA-BC, Chief Nursing Officer and Senior Vice President for ѵ Services, has been elected to the American Hospital Association’s board of trustees, where she will serve a three-year term beginning January 1, 2026; Albert, who has led efforts to reduce vacancy rates and turnover while enhancing staff engagement and retention through workforce planning initiatives, has also been a proponent of integrating virtual nursing and AI predictive modeling to improve patient care and staff efficiency, and she has been recognized with numerous awards, including induction into the New York Academy of Medicine in 2024.
Personalized Walking Pattern May Reduce Knee Osteoarthritis Symptoms, Delay Progression. (HCP Live)
(8/15) A study conducted at Stanford University, involving a randomized controlled trial, found that personalized foot angle modifications in individuals with medial compartment knee osteoarthritis may improve pain and reduce knee loading, potentially delaying surgery, according to Valentina Mazzoli, PhD, assistant professor, Department of Radiology, who said, “Although our results will have to be confirmed in future studies, they raise the possibility that the new, noninvasive treatment could help delay surgery.”
Minimally Invasive Procedure Eases Painful Symptoms Of Knee Osteoarthritis. (Scienmag)
(8/15) A study by NYU Langone Health, published in the Journal of Vascular and Interventional Radiology, reveals that genicular artery embolization, a minimally invasive procedure, can significantly alleviate chronic knee pain from osteoarthritis by targeting abnormal blood vessels that exacerbate inflammation; over 60% of the 25 patients in the trial reported improvements in pain, function, and stiffness one year post-procedure, with Ryan Hickey, MD, associate professor, Department of Radiology, section chief, Vascular Interventional Radiology, saying the procedure “not only provides symptomatic relief but might also influence the natural history of osteoarthritis by modifying underlying disease processes.”
FDA Warns ѵ Unapproved Thyroid Pills – Then Says It’ll ‘Ensure Access’ To Them. (NBC News)
(8/14) The FDA recently announced concerns about unapproved animal-derived thyroid medications due to safety and effectiveness issues, prompting an intent to take action against such products, but FDA Commissioner Marty Makary later expressed commitment to pursuing approval for desiccated thyroid extract pending trial results, while ensuring access; Michael A. Weintraub, MD, clinical assistant professor, Department of Medicine, Division of Endocrinology, Diabetes, & Metabolism said animal-derived pills can pose risks due to inconsistent hormone levels, and emphasized the importance of precise dosing, warning that incorrect levels can lead to severe health issues such as heart rhythm disturbances and bone degradation.
If You’re Dealing With Unexplained Fatigue, Do This ASAP. (Parade Magazine)
(8/14) Taylor Swift discussed her father Scott Swift’s quintuple bypass surgery on the New Heights podcast, revealing his heart blockages were discovered through a resting stress test, which cardiologists clarify is likely a nuclear medicine myocardial perfusion study, or “stress test,” involving medication to mimic exercise; Lawrence Phillips, MD, associate professor, Department of Medicine, the Leon H. Charney Division of Cardiology, NYU Langone Heart, explained that this test can diagnose heart disease effectively with a medication mimicking the effects of exercise safely.
FDA OKs Treatment For Non-Cystic Fibrosis Bronchiectasis, A Chronic Lung Disease. (ROI-NJ (NJ))
(8/14) The FDA has approved Insmed Inc.’s Brinsupri, marking it as the first and only treatment for non-cystic fibrosis bronchiectasis, with Doreen Addrizzo-Harris, MD, the Fiona and Stanley Druckenmiller Professor of Pulmonary, Critical Care and Sleep Medicine, and SPEN investigator, saying, “This FDA approval represents a potential paradigm shift in how we approach non-cystic fibrosis bronchiectasis,”
FDA Shares Safety Data ѵ ‘Adverse Events’ From Compounded Weight Loss Drugs. (Everyday Health)
(8/14) The FDA has raised concerns about compounded GLP-1 weight loss drugs, with 605 adverse event reports for semaglutide and 545 for tirzepatide, noting many pharmacies aren’t required to report such events; Melanie R. Jay, MD, professor, Department of Medicine, Division of General Internal Medicine and Clinical Innovation, and Department of Population Health, explained that dosing errors may occur more frequently with these compounded drugs because patients often need to draw medication from vials, unlike brand-name drugs with prefilled pens.
Ulcerative Colitis Poop: Appearance, Symptoms And Treatment. (Health Central)
(8/14) Gastroenterologists, including Simon J. Hong, MD, clinical associate professor, Department of Medicine, Division of Gastroenterology and Hepatology, Inflammatory Bowel Disease Center, emphasize that the appearance and frequency of bowel movements in individuals with ulcerative colitis (UC) can reveal important indicators of disease activity, with the Bristol Stool Chart being a useful tool to assess stool consistency.
Legionnaires’ Outbreak Tied To City-Run Buildings, Officials Say. (Harlem (NY) Patch)
ճ (8/14) City officials in Harlem released a list of buildings with contaminated cooling towers linked to an outbreak of Legionnaires’ disease, affecting 12 buildings, including a public hospital and a CUNY building, with 11 towers remediated and the last to be cleared by Friday, according to Mayor Eric Adams; the outbreak, first detected on July 25, resulted in three deaths and 92 illnesses, with 15 currently hospitalized, and is spread by inhaling contaminated vapor, not through person-to-person contact, according to city data and Peter Collin, MD, clinical associate professor, Department of Medicine, Division of General Internal Medicine and Clinical Innovation, and Infectious Diseases and Immunology, who said, “If people are experiencing those symptoms, they should be reaching out to their doctor right away.”
Australia Passes Social Media Ban For Children Younger Than 16. (Fox News)
(8/14) Devi E. Nampiaparampil, MD, clinical associate professor, Department of Rehabilitation Medicine, “shares her perspective on Australia’s move to ban social media for children younger than 16 on ‘Fox News Live.’”
News from NYU Langone Hospital—Suffolk
Revolutionizing Cancer Treatment: Innovations In Surgery And Pharmacology. (ReachMD)
(8/14) Advancements in cancer treatment, including robotic-assisted surgeries and drug delivery innovations, are improving recovery and reducing complications, with NYU Langone Hospital—Suffolk exemplifying these trends through minimally invasive procedures that shorten hospital stays and decrease complications; intraoperative imaging techniques like ICG fluorescence enhance surgical precision, while localized pharmacological systems, such as the TAR-200 for bladder cancer, and systemic therapies, including durvalumab combined with gemcitabine and cisplatin for advanced biliary tract cancers, demonstrate promising outcomes, although equitable access, training, and adherence to guidelines remain essential for widespread benefit.
